WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC

Now Viewing

EP: 1.WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC

EP: 2.WCLC Updates on the Emergence of ADCs in NSCLC

EP: 3.WCLC Updates in Immunotherapy for NSCLC

EP: 4.WCLC Updates in Neoadjuvant Therapy for NSCLC

EP: 5.WCLC Updates in Locally Advanced NSCLC

EP: 6.WCLC Updates in Small Cell Lung Cancer

Data from the following clinical trials are discussed:

• PS0 1.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non–Small Cell Lung Cancer
• OA04.03 - Mobocertinib in NSCLC With EGFR Exon 20 Insertions: Results From EXCLAIM and Pooled Platinum-Pretreated Patient Populations
• OA04.04 - Amivantamab in Postplatinum EGFR Exon 20 Insertion Mutant Non–Small Cell Lung Cancer